Piceatannol

Piceatannol

SCHEMBL43541

Oc1cc(O)cc(/C=C/c2ccc(O)c(O)c2)c1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LCK P06239 6/20 1.00
TP53 P04637 3/20 1.00
CYP1A2 P05177 3/20 1.00
CYP3A4 P08684 3/20 1.00
CYP2C9 P11712 3/20 1.00
HIF1A Q16665 3/20 1.00
HSD17B10 Q99714 3/20 1.00
KDM4E B2RXH2 3/20 1.00
MEN1 O00255 3/20 1.00
ALDH1A1 P00352 3/20 1.00
LMNA P02545 3/20 1.00
MAPT P10636 3/20 1.00
HPGD P15428 3/20 1.00
KMT2A Q03164 3/20 1.00
SMN1; SMN2 Q16637 3/20 1.00
TTR P02766 3/20 1.00
ALOX5 P09917 3/20 1.00
ALOX12 P18054 2/20 1.00
PKM P14618 2/20 1.00
ALOX15 P16050 2/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Piceatannol SCHEMBL29929133 1.00 LCK (1.00) LCKTP53CYP1A2CYP3A4CYP2C9
Piceatannol SCHEMBL29754702 1.00 LCK (1.00) LCKTP53CYP1A2CYP3A4CYP2C9
Piceatannol SCHEMBL29501290 1.00 LCK (1.00) LCKTP53CYP1A2CYP3A4CYP2C9
Piceatannol SCHEMBL19953785 1.00 LCK (1.00) LCKTP53CYP1A2CYP3A4CYP2C9
Piceatannol SCHEMBL505561 1.00 LCK (1.00) LCKTP53CYP1A2CYP3A4CYP2C9
SCHEMBL15026144 0.95 LCK (0.91) LCKTP53CYP1A2CYP3A4CYP2C9
SCHEMBL1932873 0.95 LCK (0.91) LCKTP53CYP1A2CYP3A4CYP2C9
SCHEMBL31706727 0.88 LCK (1.00) LCKTP53CYP1A2CYP3A4CYP2C9
SCHEMBL1824175 0.88 LCK (1.00) LCKTP53CYP1A2CYP3A4CYP2C9
SCHEMBL30631591 0.88 LCK (1.00) LCKTP53CYP1A2CYP3A4CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 8878 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2026107510-A1 HOT-MELT ADHESIVE COMPOSITION AND METHOD OF APPLICATION BIOBOND ADHESIVES, INC. (US) 2026-05-21 WO claimed
EP-4743071-A2 DIPHENYLETHYLENE COMPOUNDS AND COMPOSITIONS THEREOF INNOVENE INC. (US) 2026-05-20 EP claimed
US-20260130395-A1 Water Dispersible Botanical Compositions AQUILA BLACK LTD (AU) 2026-05-14 US claimed
WO-2026087680-A1 TREATMENT FOR CARDIOVASCULAR DISEASE SAPREME TECHNOLOGIES B.V. (NL) 2026-04-30 WO claimed
WO-2026087695-A1 TREATMENT FOR METABOLIC DISORDER SAPREME TECHNOLOGIES B.V. (NL) 2026-04-30 WO claimed
EP-4727376-A1 METHOD FOR ALTERING THE ALCOHOL PERCEPTION OR FLAVOUR OF A CONSUMABLE PREPARATION Döhler GmbH (DE) 2026-04-22 EP claimed
US-20260097056-A1 SYK ACTIVATORS AND INHIBITORS IN NEURODEGENERATIVE DISEASES UNIV VIRGINIA PATENT FOUNDATION (US) 2026-04-09 US claimed
US-20260078269-A1 POLYMERIC COMPOSITIONS WITH STILBENE-BASED PROCESSING AIDS Cambium Biomaterials, Inc. (US) 2026-03-19 US claimed
EP-4687856-A2 GLP-1R AGONIST AND DPP-4 INHIBITOR COMPOSITIONS AND METHODS OF USING JDS Therapeutics, LLC (US) 2026-02-11 EP claimed
EP-4676470-A2 DILEUCINE COMPOSITIONS AND METHODS OF USE THEREOF Ingenious Ingredients, LP (US) 2026-01-14 EP claimed
US-6124364-A Desquamation/epidermal renewal of the skin and/or combating skin aging SOCIETE L'OREAL S.A. (FR) 2000-09-26 US claimed
US-6121269-A TOPICALLY APPLYING A PROTEIN-TYROSINE KINASE INHIBITOR TO SKIN TO REDUCE ANDROGEN-STIMULATED HAIR GROWTH WITHOUT SIDE EFFECTS GILLETTE COMPANY, THE, A DELAWARE CORPORATION 2000-09-19 US claimed
WO-2000050002-A1 REDUCTION OF HAIR GROWTH THE GILLETTE COMPANY (US) 2000-08-31 WO claimed
EP-1029530-A1 Use of 3-substituted stilbene derivatives as deodorizing active principles in cosmetic compositions L'OREAL (FR) 2000-08-23 EP claimed
EP-1013260-A2 Use of hydroxystilbenes for dyeing, ready-to-use composition containing them and dyeing process L'OREAL (FR) 2000-06-28 EP claimed
WO-1999059561-A2 RESVERATROL INHIBITION OF MYELOPEROXIDASE HENSLEY, KENNETH, L. 1999-11-25 WO claimed
EP-0953346-A1 Use of at least a hydroxystilbebe in a skin fortifying composition L'OREAL (FR) 1999-11-03 EP claimed
EP-0953345-A1 Use of at least a hydroxystilbene as an agent for decreasing micro-organism adhesion L'OREAL (FR) 1999-11-03 EP claimed
EP-0953344-A1 Use of at least one hydroxystilbene in a composition to stimulate desquamation of the skin and compositions containing it L'OREAL (FR) 1999-11-03 EP claimed
US-5968517-A Process for extraction of proanthocyanidins from botanical material DUNCAN KELVIN WINSTON (NZ) 1999-10-19 US claimed